AAPEP Pharmaceuticals is developing a novel antibiotic to combat antibiotic-resistant bacteria such as MRSA (methicillin-resistant staphylococcus aureus), VREF (vancomycin-resistant enterococcus faecium), and E. Coli.
AAPEP Pharmaceuticals is developing a novel antibiotic to combat antibiotic-resistant bacteria such as MRSA (methicillin-resistant staphylococcus aureus), VREF (vancomycin-resistant enterococcus faecium), and E. Coli.